Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The findings were published in the Annals of Internal Medicine based on data from the CDCs NEISS-CADES project
In this comprehensive article well explore what FOXO4-DRI is, how it works, the current pre-clinical evidence, its promise and limitations, comparisons with other senolytic approaches, safety and regulatory considerations, and what the future might hold for integrating this novel peptide into a clinical strategy for healthier ageing
Costs were accounted in 2019 USD, from the perspective of a healthcare payer in the US
Clin Nephrol 2003;59(1):24-30
US$ 25.24
US$ 25.45
US$ 24.26
US$ 21.67
US$ 24.49
US$ 27.38
